{"entity":{"type":"insider","cik":"0001912570","url":"/insider/0001912570","json_url":"/insider/0001912570.json","name":"Goin Kathleen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":10,"first":"2025-11-21","last":"2026-08-20","span_basis":"filed_date"},"name_variants":[{"name":"Goin Kathleen","source":"filing","n_filings":10,"first_seen":"2025-11-21","last_seen":"2026-08-20"}],"transactions":[{"id":9299010,"accession":"0001104659-26-099222","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-26-099222","line_url":"/filing/0001104659-26-099222","is_derivative":false,"issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_ticker":"PVLA","issuer_name_source":null,"issuer_url":"/issuer/0001583648","owner_cik":"0001912570","owner_name":"Goin Kathleen","owner_display_name":"Goin Kathleen","owner_url":"/insider/0001912570","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4302.0,"shares_display":"4,302","price_per_share":152.2061608089261,"price_display":"152.21","price_state":"stated","total_value":654790.9038,"total_display":"654,790.90","total_whole":"654,791","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"insider","n_lines":5},{"id":5761797,"accession":"0001104659-26-084620","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-26-084620","line_url":"/filing/0001104659-26-084620","is_derivative":false,"issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_ticker":"PVLA","issuer_name_source":null,"issuer_url":"/issuer/0001583648","owner_cik":"0001912570","owner_name":"Goin Kathleen","owner_display_name":"Goin Kathleen","owner_url":"/insider/0001912570","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4302.0,"shares_display":"4,302","price_per_share":149.2774270571827,"price_display":"149.28","price_state":"stated","total_value":642191.4912,"total_display":"642,191.49","total_whole":"642,191","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-15","filed_date":"2026-07-17","scope":"insider","n_lines":4},{"id":5781593,"accession":"0001104659-26-076460","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-26-076460","line_url":"/filing/0001104659-26-076460","is_derivative":false,"issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_ticker":"PVLA","issuer_name_source":null,"issuer_url":"/issuer/0001583648","owner_cik":"0001912570","owner_name":"Goin Kathleen","owner_display_name":"Goin Kathleen","owner_url":"/insider/0001912570","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4302.0,"shares_display":"4,302","price_per_share":110.73290785681078,"price_display":"110.73","price_state":"stated","total_value":476372.9696,"total_display":"476,372.97","total_whole":"476,373","shares_owned_after":1912.0,"shares_owned_after_display":"1,912","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-17","filed_date":"2026-06-22","scope":"insider","n_lines":3},{"id":6056841,"accession":"0001104659-26-065692","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-26-065692","line_url":"/filing/0001104659-26-065692","is_derivative":false,"issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_ticker":"PVLA","issuer_name_source":null,"issuer_url":"/issuer/0001583648","owner_cik":"0001912570","owner_name":"Goin Kathleen","owner_display_name":"Goin Kathleen","owner_url":"/insider/0001912570","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4302.0,"shares_display":"4,302","price_per_share":110.56041527196653,"price_display":"110.56","price_state":"stated","total_value":475630.9065,"total_display":"475,630.91","total_whole":"475,631","shares_owned_after":939.0,"shares_owned_after_display":"939","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-20","filed_date":"2026-05-22","scope":"insider","n_lines":3},{"id":5808265,"accession":"0001104659-26-044895","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001104659-26-044895","line_url":"/filing/0001104659-26-044895","is_derivative":false,"issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_ticker":"PVLA","issuer_name_source":null,"issuer_url":"/issuer/0001583648","owner_cik":"0001912570","owner_name":"Goin Kathleen","owner_display_name":"Goin Kathleen","owner_url":"/insider/0001912570","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4302.0,"shares_display":"4,302","price_per_share":127.2429049511855,"price_display":"127.24","price_state":"stated","total_value":547398.9771,"total_display":"547,398.98","total_whole":"547,399","shares_owned_after":2800.0,"shares_owned_after_display":"2,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-17","scope":"insider","n_lines":5},{"id":5928254,"accession":"0001104659-26-032695","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-26-032695","line_url":"/filing/0001104659-26-032695","is_derivative":false,"issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_ticker":"PVLA","issuer_name_source":null,"issuer_url":"/issuer/0001583648","owner_cik":"0001912570","owner_name":"Goin Kathleen","owner_display_name":"Goin Kathleen","owner_url":"/insider/0001912570","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4302.0,"shares_display":"4,302","price_per_share":117.99418582054858,"price_display":"117.99","price_state":"stated","total_value":507610.9874,"total_display":"507,610.99","total_whole":"507,611","shares_owned_after":2034.0,"shares_owned_after_display":"2,034","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-18","filed_date":"2026-03-20","scope":"insider","n_lines":3},{"id":5820903,"accession":"0001104659-26-018136","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-26-018136","line_url":"/filing/0001104659-26-018136","is_derivative":false,"issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_ticker":"PVLA","issuer_name_source":null,"issuer_url":"/issuer/0001583648","owner_cik":"0001912570","owner_name":"Goin Kathleen","owner_display_name":"Goin Kathleen","owner_url":"/insider/0001912570","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4302.0,"shares_display":"4,302","price_per_share":79.39661715481172,"price_display":"79.40","price_state":"stated","total_value":341564.247,"total_display":"341,564.25","total_whole":"341,564","shares_owned_after":1276.0,"shares_owned_after_display":"1,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-18","filed_date":"2026-02-20","scope":"insider","n_lines":2},{"id":6014432,"accession":"0001104659-26-006237","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-26-006237","line_url":"/filing/0001104659-26-006237","is_derivative":false,"issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_ticker":"PVLA","issuer_name_source":null,"issuer_url":"/issuer/0001583648","owner_cik":"0001912570","owner_name":"Goin Kathleen","owner_display_name":"Goin Kathleen","owner_url":"/insider/0001912570","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4302.0,"shares_display":"4,302","price_per_share":97.62506508600652,"price_display":"97.63","price_state":"stated","total_value":419983.03,"total_display":"419,983.03","total_whole":"419,983","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-21","filed_date":"2026-01-23","scope":"insider","n_lines":2},{"id":4064634,"accession":"0001104659-25-123109","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-123109","line_url":"/filing/0001104659-25-123109#line-3","is_derivative":false,"issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_ticker":"PVLA","issuer_name_source":null,"issuer_url":"/issuer/0001583648","owner_cik":"0001912570","owner_name":"Goin Kathleen","owner_display_name":"Goin Kathleen","owner_url":"/insider/0001912570","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4302.0,"shares_display":"4,302","price_per_share":96.472,"price_display":"96.47","price_state":"stated","total_value":415022.544,"total_display":"415,022.54","total_whole":"415,023","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-17","filed_date":"2025-12-19","scope":"insider"},{"id":4141560,"accession":"0001104659-25-115017","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-25-115017","line_url":"/filing/0001104659-25-115017","is_derivative":false,"issuer_cik":"0001583648","issuer_name":"PALVELLA THERAPEUTICS, INC.","issuer_ticker":"PVLA","issuer_name_source":null,"issuer_url":"/issuer/0001583648","owner_cik":"0001912570","owner_name":"Goin Kathleen","owner_display_name":"Goin Kathleen","owner_url":"/insider/0001912570","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4302.0,"shares_display":"4,302","price_per_share":86.23089274755928,"price_display":"86.23","price_state":"stated","total_value":370965.3006,"total_display":"370,965.30","total_whole":"370,965","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-19","filed_date":"2025-11-21","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":30,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001583648","name":"PALVELLA THERAPEUTICS, INC.","url":"/issuer/0001583648","role":"Officer (Chief Operating Officer)","n_filings":10,"first_seen":"2025-11-21","last_seen":"2026-08-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001912570","retrieved_at":"2026-08-25T06:02:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}